Uni-Bio Science Group Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Uni-Bio Science Group Limited with three other
companies in this sector in Hong Kong:
Rui Kang Pharmaceutical Group Investments Ltd
sales of 86.57 million Hong Kong Dollars [US$11.09 million]
China Merchants China Direct Investments Limited
(201.80 million Hong Kong Dollars [US$25.84 million]
of which 48%
was Financial Services), and
Tianda Pharmaceuticals Ltd
(192.78 million Hong Kong Dollars [US$24.69 million]
of which 100%
was Pharmaceutical and Biotechnology Busines).
Uni-Bio Science Group Limited reported sales of HK$146.49 million (US$18.76 million)
December of 2016.
increase of 18.7%
versus 2015, when the company's sales were HK$123.36 million.
This was the fourth straight year of sales growth at Uni-Bio Science Group Limited.
Sales of In-House Chemical Pharmaceutical Products saw an increase
that was more than double the company's growth rate: sales were up
46.3% in 2016, from
HK$41.35 million to HK$60.49 million.